Neopharm Obesity Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Neopharm Obesity General Information

Description

Operator of a firm intended for the development and research of genomic medicine based in Spain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Seville
  • Spain
Primary Industry
Biotechnology
Corporate Office
  • Seville
  • Spain

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neopharm Obesity Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neopharm Obesity‘s full profile, request access.

Request a free trial

Neopharm Obesity FAQs

  • Where is Neopharm Obesity headquartered?

    Neopharm Obesity is headquartered in Seville, Spain.

  • What industry is Neopharm Obesity in?

    Neopharm Obesity’s primary industry is Biotechnology.

  • Is Neopharm Obesity a private or public company?

    Neopharm Obesity is a Private company.

  • What is Neopharm Obesity’s current revenue?

    The current revenue for Neopharm Obesity is .

  • When was Neopharm Obesity acquired?

    Neopharm Obesity was acquired on 01-Jan-2013.

  • Who acquired Neopharm Obesity?

    Neopharm Obesity was acquired by Landsteiner Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process